{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:36:34Z","timestamp":1790674594302,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ijantimicag.2019.07.008","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T15:50:46Z","timestamp":1563205846000},"page":"824-828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical outcomes following treatment of Enterobacter species pneumonia with piperacillin\/tazobactam compared to cefepime or ertapenem"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3183-5214","authenticated-orcid":false,"given":"Maya R.","family":"Holsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn C.","family":"Wardlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose A.","family":"Bazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn A.","family":"Fussner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelci E.","family":"Coe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5690-471X","authenticated-orcid":false,"given":"Jessica L.","family":"Elefritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl_A","key":"10.1016\/j.ijantimicag.2019.07.008_bib0001","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/29.suppl_A.19","article-title":"Predominant pathogens in hospital infections","volume":"29","author":"Jarvis","year":"1992","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.ijantimicag.2019.07.008_bib0002","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1016\/0002-9343(91)90346-Y","article-title":"Major trends in the microbial etiology of nosocomial infection","volume":"91","author":"Schaberg","year":"1991","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.ijantimicag.2019.07.008_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00276-17","article-title":"Piperacillin-tazobactam versus other antibacterial agents for treatment of bloodstream infections due to AmpC beta-lactamase-producing Enterobacteriaceae","volume":"61","author":"Cheng","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.ijantimicag.2019.07.008_bib0004","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkm318","article-title":"Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis","volume":"60","author":"Schwaber","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.ijantimicag.2019.07.008_bib0005","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/QCO.0b013e32833f0d3e","article-title":"Multiresistant Gram-negative infections: a global perspective","volume":"23","author":"Ho","year":"2010","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"10.1016\/j.ijantimicag.2019.07.008_bib0006","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/cid\/cit395","article-title":"The use of cefepime for treating AmpC beta-lactamase-producing Enterobacteriaceae","volume":"57","author":"Tamma","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ijantimicag.2019.07.008_bib0007","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/cid\/ciu182","article-title":"Cefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia","volume":"58","author":"Siedner","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijantimicag.2019.07.008_bib0008","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13756-017-0177-0","article-title":"Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case\u2013control study","volume":"6","author":"Harris","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"10.1016\/j.ijantimicag.2019.07.008_bib0009","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.clinthera.2016.11.025","article-title":"Treatment outcomes in infections caused by \"SPICE\" (Serratia, Pseudomonas, Indole-positive Proteus, Citrobacter, and Enterobacter) organisms: carbapenem versus noncarbapenem regimens","volume":"39","author":"Moy","year":"2017","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.ijantimicag.2019.07.008_bib0010","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/jac\/dkn155","article-title":"Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemia","volume":"62","author":"Marcos","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.ijantimicag.2019.07.008_bib0011","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/JCM.00404-11","article-title":"Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae","volume":"49","author":"Polsfuss","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.ijantimicag.2019.07.008_bib0012","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.diagmicrobio.2005.10.001","article-title":"Prevalence and antimicrobial susceptibility data for extended-spectrum \u03b2-lactamase\u2013and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997\u20132004)","volume":"53","author":"Goossens","year":"2005","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10","key":"10.1016\/j.ijantimicag.2019.07.008_bib0013","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2018.12163","article-title":"Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial","volume":"320","author":"Harris","year":"2018","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ijantimicag.2019.07.008_bib0014","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1128\/JCM.38.5.1791-1796.2000","article-title":"Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center","volume":"38","author":"Coudron","year":"2000","journal-title":"J Clin Microbiol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919301888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919301888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T20:32:58Z","timestamp":1610483578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919301888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0924857919301888"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.07.008","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes following treatment of Enterobacter species pneumonia with piperacillin\/tazobactam compared to cefepime or ertapenem","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}